Chartwell Investment Partners, LLC Acadia Pharmaceuticals Inc Transaction History

Chartwell Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $759,174 - $1.19 Million	-20,845 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$39.26 - $52.73 $298,415 - $400,800	-7,601 Reduced 26.72%	20,845 $1.01 Million
Q1 2020 Apr 30, 2020	BUY	$31.65 - $46.87 $101,438 - $150,218	3,205 Added 12.7%	28,446 $1.2 Million
Q4 2019 Jan 29, 2020	SELL	$36.21 - $51.4 $896,523 - $1.27 Million	-24,759 Reduced 49.52%	25,241 $1.08 Million
Q3 2019 Oct 29, 2019	BUY	$22.22 - $44.01 $1.11 Million - $2.2 Million	50,000 New	50,000 $1.8 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.73B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.